nasal cavity adenocarcinoma (Cancer)
Information
- Disease name
- nasal cavity adenocarcinoma
- Disease ID
- DOID:4930
- Description
- "A nasal cavity carcinoma that derives_from epithelial cells of glandular origin." [url:http\://en.wikipedia.org/wiki/Adenocarcinoma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02834013 | Active, not recruiting | Phase 2 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | January 30, 2017 | May 1, 2026 |
| NCT03274414 | Completed | Phase 2 | A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages | September 1, 2017 | January 13, 2023 |
- Disase is a (Disease Ontology)
- DOID:4931
- Cross Reference ID (Disease Ontology)
- NCI:C6015
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C1334920
- Exact Synonym (Disease Ontology)
- adenocarcinoma of the nasal cavity
- Disase Synonym (Disease Ontology)
- adenocarcinoma of nasal cavity